Fred R. Hirsch, from the University of Colorado and IASLC, discusses some of the unique challenges he faced as a patient.
BY Fred R. Hirsch
PUBLISHED September 03, 2015
Fred R. Hirsch, professor of medicine, professor in pathology, University of Colorado, CEO, International Associate for the Study of Lung Cancer (IASLC), discusses some of the unique challenges he faced as a patient.
When Hirsch was diagnosed with lymphoma, he had been practicing medical oncology for 20 years. Before that moment, Hirsch admits, he thought he knew everything about cancer and cancer treatment. Then, new perspectives came flooding in.